New listings push IPO pace ahead of last year’s
Five new listings on NASDAQ suggest persistent appetite for biotech IPOs
A spate of biotech IPOs this week in which five companies raised nearly $620 million helped push the biopharma sector’s total haul from NASDAQ listings ahead of 2018’s record pace.
Of the five to price this week, four companies were biopharmas. In that category, 24 companies have raised more than $2.4 billion via NASDAQ